C12N 2740/13051
Methods of production or purification of viral material
C12N2740/13051 (Methods of production or purification of viral material) appears on 137 US grants and 101 published applications in this corpus.
Search patents in C12N- Granted patents
- 137
- Published applications
- 101
- Assignees
- 110
- Inventors
- 289
- Latest grant
- 13 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 5 | 0 |
| 1995 | 3 | 0 |
| 1996 | 3 | 0 |
| 1997 | 9 | 0 |
| 1998 | 13 | 0 |
| 1999 | 15 | 0 |
| 2000 | 9 | 0 |
| 2001 | 10 | 1 |
| 2002 | 10 | 9 |
| 2003 | 5 | 5 |
| 2004 | 5 | 7 |
| 2005 | 3 | 4 |
| 2006 | 5 | 7 |
| 2007 | 2 | 3 |
| 2008 | 2 | 4 |
| 2009 | 2 | 4 |
| 2010 | 2 | 1 |
| 2011 | 1 | 3 |
| 2012 | 1 | 5 |
| 2013 | 1 | 1 |
| 2014 | 3 | 4 |
| 2015 | 3 | 4 |
| 2016 | 1 | 2 |
| 2017 | 2 | 1 |
| 2018 | 1 | 2 |
| 2019 | 2 | 5 |
| 2020 | 1 | 3 |
| 2021 | 4 | 4 |
| 2022 | 0 | 2 |
| 2023 | 4 | 7 |
| 2024 | 3 | 5 |
| 2025 | 4 | 4 |
| 2026 | 1 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Adjuvant compositions13 Jan 2026US 12,521,433 B2Zoetis Services LLC
- Compositions and methods for therapeutic or vaccine delivery8 Jul 2025US 12,350,327 B2GenVivo, Inc.
- Retroviral vector27 May 2025US 12,312,592 B2Oxford Biomedica (UK) Limited
- Digital-to-analog conversion apparatus and method having signal calibration mechanism21 Jan 2025US 12,203,093 B2Realtek Semiconductor Corp.
- Method of inhibiting enveloped virus binding to target cells by incorporating P-selectin glycoprotein ligand-1 (PSGL-1) into virions14 Jan 2025US 12,194,087 B2George Mason University
- Digital droplet based assay for detecting replication competent lentiviral vector1 Oct 2026US 2026/0297693 A1Sana Biotechnology, Inc.
- Dual targeted gene therapy17 Sep 2026US 2026/0275377 A1Kelonia Therapeutics, Inc.
- Pseudotyped viral particles for targeting tcr-expressing cells6 Aug 2026US 2026/0226500 A1Regeneron Pharmaceuticals, Inc.
- Transduction of gammadelta T cells with pseudotyped retroviral vectors28 May 2026US 2026/0146260 A1Miltenyi Biotec GmbH
- Retroviral and Lentiviral Vectors25 Dec 2025US 2025/0388929 A1Autolus Limited
Most cited
By later US patents
- DNA constructs for retrovirus packaging cell lines249US 4,861,719 AFred Hutchinson Cancer Research Center · 1989
- Recombination resistant retroviral helper cell and products produced thereby142US 5,124,263 AWisconsin Alumni Research Foundation · 1992
- Internal ribosome entry site, vector containing it and therapeutic use107US 5,925,565 AInstitut National de la Sante et de la Recherche Medicale · 1999
- Retroviral packaging cell lines and process of using same102US 5,278,056 AThe Trustees of Columbia University in the City of New York · 1994
- Compositions and methods for identifying antigens which elicit an immune response89US 6,500,641 B1Wake Forest University School of Medicine · 2002